TRIFENS

pharmaceuticals, for use in the treatment of actinic keratosis, kaposi's sarcoma, basal cell carcinoma, cancers (all types, including leukemia and other blood types), sickle cell anemia, restenosis, atherosclerosis, diabetic retinopathy, arteriosclerosis, diseases characterized by neovascularization, dermatologic condition, and gastro intestinal diseases